Soild Tumors clinical trials

Explore recruiting soild tumors clinical trials.

Also recruiting in Europe

Soild Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A first in human Phase 1/2 open-label, multicenter, dose escalation and expansion study of PRS-344/S095012 in patients with solid tumors.

Spain, France, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Soild Tumors trials by city

Soild Tumors in Toronto Soild Tumors in Vancouver Soild Tumors in Montreal Soild Tumors in Calgary Soild Tumors in Edmonton Soild Tumors in Ottawa Soild Tumors in Winnipeg Soild Tumors in Quebec City Soild Tumors in Hamilton Soild Tumors in Kitchener Soild Tumors in London Soild Tumors in Halifax Soild Tumors in New York Soild Tumors in Los Angeles Soild Tumors in Chicago Soild Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease